#IMS2025 kicks off at Toronto, CA!

Announcing the 1st paper of ‪@thelancethaem.bsky.social‬ Commission on Adverse Events, with Drs. @biostatgirl.bsky.social‬ & Thanarajasingam. We review advances in measuring & reporting newly-described AEs and provide analytic & AE visualization tools for dissemination. buff.ly/SchRHhq Thread ⬇️🧵

What steps can trialists, regulators, journals, editors, reviewers, sponsors & academics take to improve toxicity reporting & identification? 👇 check out this figure from our @thelancethaem.bsky.social adverse event commission www.thelancet.com/journals/lan... @broeckelmann.bsky.social

AI for research: the ultimate guide to choosing the right tool "Curious about using artificial intelligence to boost your research? Here are the programs you shouldn’t miss." www.nature.com/articles/d41...

#iwCART25 day 1 covered current state of #CellTherapy in solid tumors, CLL & ALL. Day 2 opens with activities in the next frontier: autoimmune disorders. @vjhemonc.bsky.social keynote speaker Dr. David Porter.

Women Cancer Advocates: Champions of Hope and Inspiration🎗️ 🌍This International Women’s Day, we honor eight inspiring women, including late and living celebrities, who have advocated for early cancer detection and prevention through collaborations with health organizations.

Bright sunny day in Minnesota to travel to Osaka Japan. Looking forward to international exchange in #CARTtherapy #JSTCT2025

Great inaugural #NashvilleHeme25: timely clinical data updates, relevant practical information, fun debates! All at the capitol of country music. Save the date for #NashvilleHeme26

Great venue for the inaugural #nashvilleheme25 at Country Music Hall of Fame! Hematologists know how to make CME fun.

Our International Society of Cell & Gene Therapy @isctglobal.bsky.social MSC committee has published this statement on the US FDA approval of allogenic Bone Marrow- derived mesenchymal stem/stromal cells. www.sciencedirect.com/science/arti...

I guess the lunar new year luck rubbed off on my son. He passed his driving test. Watch out, Rochester: another teenager on the road!

Relive the excitement of #ASH24 and discover other sides of the Society that pique your interest. The official meeting newscast ASH News TV is online! 📺Watch here: bit.ly/4fhpC56 #HemeSky #Hematology #BloodSky

Happy to welcome #ASTCT to @bsky.app Follow @astct.bsky.social as we prepare for #Tandem25 in Honolulu #bmtsm #CARTcells #genetherapy

Can we avoid the Chekov’Gun Dilemma in #CART therapy decision making? Dr. Rejeski presents prediction model at the time of eval, prior to leukapheresis #ASH24 data from >800 #mmsm pts (abstract 895) @drmiguelperales.bsky.social

Catching up with our Myeloma, Amyloidosis, and Dysproteinemia colleagues across Mayo Clinic sites at #ASH24. @yilinmdphd.bsky.social @leifbergsagel.bsky.social @lbaughn.bsky.social @vincentrk.bsky.social

Airy spheres ascend, Colors dance in vivid light— Come see the bubbles. #ASHaiku #ASH24 Now through 1 p.m. at the amphitheater (bay side of the SDCC) #Hemesky #hematology

#ASH24 #ASHselfies with @ouholter.bsky.social Marcelo Pasquini @bldcancerdoc.bsky.social @yilinmdphd.bsky.social Ryo Nakamura & Veronica Bachanova - great time to reconnect with friends at the poster session

Congrats to Michelle Wang @atulbutte.bsky.social @ucsfcancer.bsky.social for her oral presentation demonstrating utility of #AI to predict outcomes after CAR-T therapy for #lymphoma. Machine learning identified age and four lab values measured within 24h of infusion as predictive of relapse. #ASH24

Activated #CART cell or megakaryocyte? Either way, color matches my shirt 😆 trying to grab #ASH24 souvenir before they are gone!

#ASH24 mascot celebrity sight

Annual pre-holiday trek to warmer weather and even more exciting exchange #ASH24